Sunshine Biopharma Inc.
13F holders, Q3 2024 (September 30)10holders
$3.18avg. 13F price*
At the end of Q3 2024, 10 institutions reported holding Sunshine Biopharma Inc. in their 13F filings. The largest holders were Bank of America Corp. ($110K), Nordwand Advisors, LLC ($2K) and National Bank of Canada ($22).
- Company
- Sunshine Biopharma Inc.
- CUSIP
- 867781700
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $111K |
| Exits | 0 | $0 |
Ownership 10 holders
| Bank of America Corp. | 0.00% | New | 34,480 | $110K |
| Nordwand Advisors, LLC | 0.00% | New | 500 | $2K |
| National Bank of Canada | 0.00% | New | 7 | $22 |
| Morgan Stanley | 0.00% | New | 1 | $3 |
| Jaffetilchin Investment Partners, LLC | 0.00% | New | 1 | $3 |
| Osaic Holdings, Inc. | 0.00% | New | 1 | $3 |
| Rise Advisors, LLC | 0.00% | New | 1 | $3 |
| Farther Finance Advisors, LLC | 0.00% | New | 1 | $3 |
| TD Waterhouse Canada Inc. | 0.00% | New | 1 | $3 |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 1 | $3 |
"% of holder's portfolio" is SUNSHINE BIOPHARMA INC's weight in each manager's 13F, not the share of Sunshine Biopharma Inc. the manager owns.